"急性骨髄性白血病" の関連情報検索結果

  • News
  • Q&A
  • Shopping
  • Auction
  • Rakuten
  • amazon

FDA Grants Breakthrough Therapy Designation to Ziftomenib in NPM1-Mutant AML - OncLive



FDA Grants Breakthrough Therapy Designation to Ziftomenib in NPM1-Mutant AML  OncLive